Eton Pharmaceuticals ETON
NASDAQ ETON
$55.36 +3.38 (+6.50%)
At close: Oct 2, 2026 · 4:00 PM EDT

Eton Pharmaceuticals (ETON) Other Accumulated Expenses (2023 - 2025)

Updated

Eton Pharmaceuticals (ETON) reported Other Accumulated Expenses of $675,000 for Q1 2025.

Analysis

Eton Pharmaceuticals (ETON) Other Accumulated Expenses (2023 - 2025) Analysis & Trends

At the end of FY2023, Eton Pharmaceuticals posted Other Accumulated Expenses of $5.39 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Eton Pharmaceuticals 1.57 Bn 1.45 Bn 25.41 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2025 675,000.00
Sep 30, 2024 4.88 Mn
Dec 31, 2023 5.39 Mn
API Access

Eton Pharmaceuticals Other Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=ETON&period=max&api_key=YOUR_API_KEY